Momentus Inc. Announces Third Quarter 2021 Financial Results
Momentus Inc. (NASDAQ: MNTS) reported its Q3 2021 financial results, highlighting major milestones such as the successful business combination with Stable Road, which improved liquidity for future operations. The company added experienced leaders from defense sectors and made significant progress in implementing its National Security Agreement. Key developments included advancements in the Vigoride vehicle's assembly and testing, securing a Launch Services Agreement for a June 2022 mission, and settling all obligations with the SEC. These steps collectively position Momentus to enhance its infrastructure services in space.
- Completed a business combination with Stable Road, bolstering liquidity.
- Added experienced executives from the defense sector to leadership.
- Significant progress in implementing the National Security Agreement.
- Advancements in Vigoride vehicle assembly and testing.
- Secured a Launch Services Agreement for June 2022 mission.
- Current launch plans subject to government approvals and system readiness.
“During the third quarter, we took major steps toward our goal of providing the transportation and infrastructure services that will enable people, companies and industries to use space in exciting new ways,” said
Third Quarter 2021 Business Highlights:
-
Completed a business combination with
Stable Road Acquisition Corporation , which effectively listed the company’s equity on theNasdaq Global Select Markets stock exchange and bolstered the Company’s liquidity position to fund the next phase of its business plan. -
Added key defense and security experience to the executive leadership team including the addition of
John C. Rood , formerU.S. Under Secretary of Defense for Policy, as the Company’s new Chief Executive Officer as well as the additions ofPaul Ney , former General Counsel for theDepartment of Defense as the Company’s new Chief Legal Officer, andKaren Plonty as the Company’s new Chief Security Officer. -
Reconstituted the Board of Directors for effective public company governance including the appointment of
Victorino Mercado , former Assistant Secretary of Defense for Strategy, Plans, and Capabilities, as the Company’s new Security Director to oversee implementation of the National Security Agreement (NSA) that the Company signed with CFIUS in June. -
Made significant progress under new leadership toward
NSA implementation. Of the 62 discrete compliance tasks required under theNSA , we have fully implemented the majority and have partially implemented the remaining items. - Refocused product development strategy into actionable steps that will help build a foundation for the future. Step one is to bring our Vigoride vehicle to market as early as possible with the features and reliability we know our customers want. This will be closely followed by a focused expansion of our service offerings as we bring online a reusable version of Vigoride that we think will be able to effectively and economically support customer demands for payload hosting and in-orbit servicing.
- Completed the initial assembly and initial system-level functional testing of Vigoride 3 and drafted a plan to address anomalies uncovered by these tests. Remediation and planned rework of some components are ongoing, and the vehicle will soon enter system-level thermal vacuum testing, which is late-stage environmental testing that simulates the environment in space.
- Completed performance testing of latest-generation Microwave Electrothermal Thruster (MET) with life testing now underway. So far, the MET has performed as expected during these tests.
-
Settled all obligations related to the previously-announced repurchase of our co-founders’ shares for
.$40 million - Settled all outstanding claims with SEC Enforcement. Subsequent to the close of the quarter, we have fully engaged with an independent compliance consultant as is required by our settlement agreement.
- Subsequent to the close of the quarter, we signed a Launch Services Agreement that reserves space for Vigoride on SpaceX’s Transporter-5 mission, which is targeted for June of 2022. While securing space on the manifest is an important step, our plan to launch in June remains subject to the receipt of licenses and other government approvals, and successful completion of our current efforts to get the system ready for flight.
Conference Call Information
About
Forward-Looking Statements
This press release contains certain statements which may constitute “forward-looking statements” for purposes of the federal securities laws. Forward-looking statements include, but are not limited to, statements regarding
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.
Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Momentus’ control. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: the ability of the Company to obtain licenses and government approvals for its missions, which are essential to its operations; the ability of the Company to effectively market and sell satellite transport services and planned in-orbit services; the ability of the Company to protect its intellectual property and trade secrets; the development of markets for satellite transport and in-orbit services; the ability of the Company to develop, test and validate its technology, including its water plasma propulsion technology; delays or impediments that the Company may face in the development, manufacture and deployment of next generation satellite transport systems; the ability of the Company to convert backlog or inbound inquiries into revenue; changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business, including export control license requirements; the ability to attract or maintain a qualified workforce with the required security clearances and requisite skills; level of product service or product or launch failures or delays that could lead customers to use competitors’ services; investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; the effects of the COVID-19 pandemic on the Company’s business; the Company’s ability to comply with the terms of its National Security Agreement and any related compliance measures instituted by the director who was approved by the CFIUS Monitoring Agencies (the “Security Director”); the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and/or other risks and uncertainties included under the “Risk Factors” in the Proxy Statement/Prospectus filed by the Company on
Third Quarter 2021 Financial Results |
|||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (in thousands, except per share data) |
|||||||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
Service revenue 1 |
$ |
200 |
$ |
— |
|
|
$ |
330 |
|
|
|
$ |
— |
||||||
Cost of revenue (decrease) 2 |
(184 |
) |
|
|
— |
|
|
|
(135 |
) |
|
|
— |
|
|
||||
Gross margin |
384 |
|
|
|
— |
|
|
|
465 |
|
|
|
— |
|
|
||||
Operating expenses: |
|
|
|
|
|
|
|
||||||||||||
Research and development expenses |
9,047 |
|
|
|
5,377 |
|
|
|
39,747 |
|
|
|
13,758 |
|
|
||||
Selling, general and administrative expenses |
12,057 |
|
|
|
4,056 |
|
|
|
35,802 |
|
|
|
7,478 |
|
|
||||
Total operating expenses |
21,104 |
|
|
|
9,433 |
|
|
|
75,549 |
|
|
|
21,236 |
|
|
||||
Loss from operations |
(20,721 |
) |
|
|
(9,433 |
) |
|
|
(75,084 |
) |
|
|
(21,236 |
) |
|
||||
|
|
|
|
|
|
|
|
||||||||||||
Other income (expense): |
|
|
|
|
|
|
|
||||||||||||
Decrease (increase) in fair value of SAFE notes |
26,924 |
|
|
|
(99,107 |
) |
|
|
209,291 |
|
|
|
(102,695 |
) |
|
||||
Decrease (increase) in fair value of warrants |
(2,712 |
) |
|
|
(1,324 |
) |
|
|
9,826 |
|
|
|
(1,317 |
) |
|
||||
Interest income |
— |
|
|
|
1 |
|
|
|
2 |
|
|
|
7 |
|
|
||||
Interest expense |
(4,328 |
) |
|
|
(67 |
) |
|
|
(8,685 |
) |
|
|
(145 |
) |
|
||||
|
— |
|
|
|
— |
|
|
|
(7,000 |
) |
|
|
— |
|
|
||||
Other income (expense) 3 |
(4,778 |
) |
|
|
(993 |
) |
|
|
(4,965 |
) |
|
|
(942 |
) |
|
||||
Total other income (expense) |
15,107 |
|
|
|
(101,489 |
) |
|
|
198,469 |
|
|
|
(105,093 |
) |
|
||||
Income (loss) before income taxes |
(5,614 |
) |
|
|
(110,923 |
) |
|
|
123,385 |
|
|
|
(126,329 |
) |
|
||||
Income tax provision |
— |
|
|
|
— |
|
|
|
1 |
|
|
|
1 |
|
|
||||
Net income ( loss) |
$ |
(5,614 |
) |
|
|
$ |
(110,923 |
) |
|
|
$ |
123,384 |
|
|
|
$ |
(126,329 |
) |
|
Net income ( loss) per share, basic |
$ |
(0.09 |
) |
|
|
$ |
(1.77 |
) |
|
|
$ |
2.06 |
|
|
|
$ |
(1.97 |
) |
|
Net income ( loss) per share, fully diluted |
$ |
(0.09 |
) |
|
|
$ |
(1.77 |
) |
|
|
$ |
1.92 |
|
|
|
$ |
(1.97 |
) |
|
Weighted average shares outstanding, basic |
60,589,566 |
|
|
|
62,722,340 |
|
|
|
59,873,199 |
|
|
|
64,244,006 |
|
|
||||
Weighted average shares outstanding, fully diluted |
60,589,566 |
|
|
|
62,722,340 |
|
|
|
64,232,537 |
|
|
|
64,244,006 |
|
|
1 - |
Revenue recognized related to cancellations of customer contracts, resulting in the forfeiture of customer deposits |
|
2 - |
The reduction of cost of revenue represents the reversal of a contingency recorded during the prior year for loss contracts related to free slots on future missions. During the three months ended |
|
3 - |
Other expenses during three months ended |
|
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
|||||||||
|
|
|
|
||||||
|
(unaudited) |
|
|
||||||
ASSETS |
|
|
|
||||||
Current assets: |
|
|
|
||||||
Cash and cash equivalents |
$ |
178,059 |
|
|
|
$ |
23,005 |
|
|
Restricted cash, current |
820 |
|
|
|
100 |
|
|
||
Prepaids and other current assets |
10,408 |
|
|
|
4,508 |
|
|
||
Total current assets |
189,287 |
|
|
|
27,613 |
|
|
||
Property, machinery and equipment, net |
4,786 |
|
|
|
2,321 |
|
|
||
Intangible assets, net |
344 |
|
|
|
305 |
|
|
||
Operating right-of-use asset |
7,846 |
|
|
|
316 |
|
|
||
Deferred offering costs |
— |
|
|
|
2,610 |
|
|
||
Restricted cash, non-current |
313 |
|
|
|
415 |
|
|
||
Other non-current assets |
3,065 |
|
|
|
2,740 |
|
|
||
Total assets |
$ |
205,640 |
|
|
|
$ |
36,320 |
|
|
|
|
|
|
||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) |
|
|
|
||||||
Accounts payable |
$ |
4,755 |
|
|
|
$ |
1,863 |
|
|
Accrued expenses |
6,733 |
|
|
|
3,064 |
|
|
||
Loan payable, current |
17,613 |
|
|
|
— |
|
|
||
Contract liabilities, current |
— |
|
|
|
1,914 |
|
|
||
Operating lease liability, current |
1,146 |
|
|
|
254 |
|
|
||
Other current liabilities |
5,066 |
|
|
|
220 |
|
|
||
Total current liabilities |
35,313 |
|
|
|
7,314 |
|
|
||
Contract liabilities, non-current |
1,554 |
|
|
|
711 |
|
|
||
Warrant liability |
33,254 |
|
|
|
3,206 |
|
|
||
SAFE notes |
— |
|
|
|
314,440 |
|
|
||
Operating lease liability, non-current |
7,565 |
|
|
|
72 |
|
|
||
Other non-current liabilities |
437 |
|
|
|
49 |
|
|
||
Total liabilities |
78,122 |
|
|
|
325,792 |
|
|
||
|
|
|
|
||||||
Shareholders’ equity (deficit): |
|
|
|
||||||
Common stock, |
1 |
|
|
|
1 |
|
|
||
Additional paid-in capital |
333,471 |
|
|
|
39,866 |
|
|
||
Treasury Stock |
— |
|
|
|
— |
|
|
||
Accumulated deficit |
(205,954 |
) |
|
|
(329,338 |
) |
|
||
Total stockholders’ equity (deficit) |
127,518 |
|
|
|
(289,472 |
) |
|
||
Total liabilities and stockholders’ equity (deficit) |
$ |
205,640 |
|
|
|
$ |
36,320 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (in thousands) |
|||||||||
|
Nine Months Ended
|
||||||||
|
2021 |
|
2020 |
||||||
Cash flows from operating activities: |
|
|
|
||||||
Net income (loss) |
$ |
123,384 |
|
|
|
$ |
(126,329 |
) |
|
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
||||||
Depreciation and amortization |
768 |
|
|
|
419 |
|
|
||
Amortization of debt discount and issuance costs |
6,935 |
|
|
|
34 |
|
|
||
(Decrease) increase in fair value of warrants |
(9,826 |
) |
|
|
1,317 |
|
|
||
(Decrease) increase in fair value of SAFE notes |
(209,291 |
) |
|
|
102,695 |
|
|
||
Impairment of prepaid launch costs |
9,450 |
|
|
|
— |
|
|
||
Stock-based compensation expense |
11,187 |
|
|
|
1,642 |
|
|
||
Changes in operating assets and liabilities: |
|
|
|
||||||
Prepaids and other current assets |
(15,350 |
) |
|
|
(4,873 |
) |
|
||
Other non-current assets |
(2,908 |
) |
|
|
360 |
|
|
||
Accounts payable |
4,357 |
|
|
|
865 |
|
|
||
Accrued expenses |
4,546 |
|
|
|
1,061 |
|
|
||
Other current liabilities |
4,829 |
|
|
|
61 |
|
|
||
Contract liabilities |
(1,071 |
) |
|
|
1,681 |
|
|
||
Lease liability and right of use asset |
856 |
|
|
|
— |
|
|
||
Other non-current liabilities |
5 |
|
|
|
— |
|
|
||
Net cash used in operating activities |
(72,129 |
) |
|
|
(21,068 |
) |
|
||
|
|
|
|
||||||
Cash flows from investing activities: |
|
|
|
||||||
Purchases of property, machinery and equipment |
(2,835 |
) |
|
|
(1,245 |
) |
|
||
Purchases of intangible assets |
(16 |
) |
|
|
(99 |
) |
|
||
Net cash used in investing activities |
(2,852 |
) |
|
|
(1,345 |
) |
|
||
|
|
|
|
||||||
Cash flows from financing activities: |
|
|
|
||||||
Proceeds from issuance of SAFE notes |
30,853 |
|
|
|
44,650 |
|
|
||
Proceeds from issuance of loan payable |
25,000 |
|
|
|
2,458 |
|
|
||
Proceeds from exercise of stock options |
278 |
|
|
|
61 |
|
|
||
Payment of notes payable |
— |
|
|
|
(1,015 |
) |
|
||
Payment of debt issuance costs |
(144 |
) |
|
|
(37 |
) |
|
||
Payment of warrant issuance costs |
(31 |
) |
|
|
(1 |
) |
|
||
Payment for share repurchase |
(40,000 |
) |
|
|
— |
|
|
||
Proceeds from PIPE |
110,000 |
|
|
|
— |
|
|
||
Proceeds from issuance of common stock upon Merger |
137,282 |
|
|
|
— |
|
|
||
Payments for transaction costs |
(32,585 |
) |
|
|
— |
|
|
||
Net cash provided by financing activities |
230,653 |
|
|
|
46,116 |
|
|
||
|
|
|
|
||||||
Increase in cash, cash equivalents and restricted cash |
155,672 |
|
|
|
23,704 |
|
|
||
Cash, cash equivalents and restricted cash, beginning of period |
23,520 |
|
|
|
13,002 |
|
|
||
Cash, cash equivalents and restricted cash, end of period |
$ |
179,191 |
|
|
|
$ |
36,706 |
|
|
|
|
|
|
||||||
Supplemental disclosure of non-cash investing and financing activities |
|
|
|
||||||
Issuance of common stock related to conversion of SAFE notes |
$ |
136,001 |
|
|
|
$ |
— |
|
|
Issuance of common stock related to exercise of warrant liabilities |
$ |
7,001 |
|
|
|
$ |
— |
|
|
Reclassification of deferred offering costs |
$ |
6,203 |
|
|
|
$ |
— |
|
|
Deferred offering costs in accounts payable and accrued expenses at period end |
$ |
— |
|
|
|
$ |
979 |
|
|
Assumption of merger warrants liability |
$ |
31,225 |
|
|
|
$ |
— |
|
|
Operating lease right-of-use assets in exchange for lease obligations |
$ |
8,501 |
|
|
|
$ |
— |
|
|
|
|
|
|
||||||
Supplemental disclosure of cash flow information |
|
|
|
||||||
Cash paid for income taxes |
$ |
1 |
|
|
|
$ |
1 |
|
|
Cash paid for interest |
$ |
1,750 |
|
|
|
$ |
84 |
|
|
Reclassifications
Certain reclassifications have been made to the prior year’s financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, shareholders’ deficit, income, expenses or net losses previously reported.
Use of Non-GAAP Financial Measures (unaudited)
This press release references certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. The Company defines non-GAAP selling, general, and administrative expenses and research and development expenses as those respective GAAP amounts, excluding stock-based compensation and non-recurring items not indicative of core operating performance None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of adjusted EBITDA to net loss for the three months
|
Three Months Ended |
|||||||||||||
(in thousands) |
|
|
|
|
|
|||||||||
Net Income (Loss) |
$ |
(5,614 |
) |
|
|
$ |
(110,923 |
) |
|
|
$ |
64,327 |
|
|
Income tax expense |
— |
|
|
|
— |
|
|
|
1 |
|
|
|||
Interest income |
— |
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|||
Interest expense |
4,328 |
|
|
|
67 |
|
|
|
3,389 |
|
|
|||
Depreciation & amortization |
320 |
|
|
|
156 |
|
|
|
249 |
|
|
|||
EBITDA |
(966 |
) |
|
|
(110,701 |
) |
|
|
67,965 |
|
|
|||
(Decrease) increase in fair value of SAFE notes |
(26,924 |
) |
|
|
99,107 |
|
|
|
(100,803 |
) |
|
|||
(Decrease) increase in fair value of warrants |
2,712 |
|
|
|
1,324 |
|
|
|
(4,454 |
) |
|
|||
|
— |
|
|
|
— |
|
|
|
7,000 |
|
|
|||
Transaction costs allocated to warrant liability |
4,780 |
|
|
|
— |
|
|
|
— |
|
|
|||
Investment banking fees related to SAFE financing |
— |
|
|
|
1,005 |
|
|
|
— |
|
|
|||
Prepaid launch deposit impairment |
— |
|
|
|
— |
|
|
|
8,700 |
|
|
|||
|
2,188 |
|
|
|
— |
|
|
|
3,514 |
|
|
|||
Severance and other related expenses |
— |
|
|
|
— |
|
|
|
156 |
|
|
|||
Stock-based compensation |
3,075 |
|
|
|
1,374 |
|
|
|
2,344 |
|
|
|||
Adjusted EBITDA |
$ |
(15,136 |
) |
|
|
$ |
(7,892 |
) |
|
|
$ |
(15,578 |
) |
|
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended
|
Three Months Ended |
||||||||||
(in thousands) |
|
|
|
|
|
||||||
Selling, general, and administrative expenses |
$ |
12,057 |
|
|
$ |
4,056 |
|
|
$ |
9,740 |
|
Stock-based compensation |
$ |
3,023 |
|
|
$ |
1,339 |
|
|
$ |
2,278 |
|
|
$ |
2,188 |
|
|
$ |
— |
|
|
$ |
3,514 |
|
Severance and other related expenses |
$ |
— |
|
|
$ |
— |
|
|
$ |
76 |
|
Non-GAAP selling, general, administration expenses |
$ |
6,846 |
|
|
$ |
2,717 |
|
|
$ |
3,872 |
|
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended
|
Three Months Ended |
||||||||||
(in thousands) |
|
|
|
|
|
||||||
Research and development expenses |
$ |
9,047 |
|
|
$ |
5,377 |
|
|
$ |
20,794 |
|
Prepaid launch deposit impairment |
$ |
— |
|
|
$ |
— |
|
|
$ |
8,700 |
|
Stock-based compensation |
$ |
52 |
|
|
$ |
34 |
|
|
$ |
66 |
|
Severance and other related expenses |
$ |
— |
|
|
$ |
— |
|
|
$ |
80 |
|
|
$ |
8,995 |
|
|
$ |
5,343 |
|
|
$ |
11,948 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006522/en/
For investor relations inquiries:
For media inquiries:
Source:
FAQ
What are Momentus Inc.'s Q3 2021 financial results?
What is the status of Momentus' Vigoride vehicle?
When is Momentus planning to launch its Vigoride vehicle?
Who were the new executives appointed at Momentus?